Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–14.
Article PubMed PubMed Central CAS Google Scholar
Scarisbrick J. The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas. Presse Med. 2022;51(1):104123.
Article PubMed CAS Google Scholar
Quadri I, Reneau JC, Hanel W, Chung CG. Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors. Front Immunol. 2023;3(14):1291259.
Binamer Y. Cutaneous T-cell lymphoma in Saudi Arabia: retrospective single-center review. Ann Saudi Med. 2017;37(3):212–5.
Article PubMed PubMed Central Google Scholar
AlGhamdi KM, Arafah MM, Al-Mubarak LA, Khachemoune A, Al-Saif FM. Profile of mycosis fungoides in 43 Saudi patients. Ann Saudi Med. 2012;32(3):283–7.
Article PubMed PubMed Central Google Scholar
Alghubaywi FA, Alharthi SA, Aldharman SS, Najjar RH, Aleissa MY, Aljarbou OZ, et al. Clinicopathologic characteristics and outcomes of patients with mycosis fungoides: a single tertiary center retrospective analysis in Saudi Arabia. Saudi Med J. 2023;44(4):394–400.
Article PubMed PubMed Central Google Scholar
Alsaleh QA, Nanda A, Al-Ajmi H, Al-Sabah H, Elkashlan M, Al-Shemmari S, et al. Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991-2006. Int J Dermatol. 2010;49(12):1393–8.
Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, et al. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood. 2022;140(5):419.
Article PubMed PubMed Central CAS Google Scholar
Latzka J, Assaf C, Bagot M, Cozzio A, Dummer R, Guenova E, et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - update 2023. Eur J Cancer. 2023;195:113343.
Gilson D, Whittaker SJ, Child FJ, Scarisbrick JJ, Illidge TM, Parry EJ, et al. British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018. Br J Dermatol. 2019;180(3):496–526.
Article PubMed CAS Google Scholar
Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064–73.
Article PubMed PubMed Central CAS Google Scholar
Lachance M, Thibeault MM. Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: a retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec. Ann Dermatol Venereol. 2023;150(4):276–80.
Article PubMed CAS Google Scholar
Luo Y, Liu Z, Liu J, Liu Y, Zhang W, Zhang Y. Mycosis Fungoides and variants of Mycosis Fungoides: a retrospective study of 93 patients in a Chinese population at a single center. Ann Dermatol. 2020;32(1):14–20.
Article PubMed CAS Google Scholar
Suh KS, Jang MS, Jung JH, Kwon DI, Seong SH, Lee KH, et al. Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: a 29-year review. J Am Acad Dermatol. 2022;86(6):1275–84.
Moreno-Vílchez C, Servitje O, Íñiguez-Arroyo Ó, Muniesa C. Survival analysis and prognostic factors in a case series of 148 cutaneous T-cell lymphomas. Actas Dermosifiliogr. 2024;115(8):T766–72.
Scarisbrick JJ. Survival in Mycosis Fungoides and Sezary Syndrome: how can we predict outcome? J Invest Dermatol. 2020;140(2):281–3.
Article PubMed CAS Google Scholar
Miyashiro D, Sanches JA. Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort. Int J Dermatol. 2022;61(4):442–54.
Article PubMed CAS Google Scholar
Nikolaou V, Papadavid E, Patsatsi A, Siakantaris M, Economidi A, Marinos L, et al. Prognostic indicators for mycosis fungoides in a Greek population. Br J Dermatol. 2017;176(5):1321–30.
Comments (0)